NEW YORK (GenomeWeb News) – Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer has acquired a site license for two bioinformatics software programs from BioDiscovery.

The El Segundo, Calif.-based bioinformatics firm said that the Keystone Program will use the firm's Nexus Copy Number and Nexus Expression tools for DNA copy number and RNA expression analysis from microarray data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.